contacts Sign In
image
author Image

Biogen to cut 1,000 jobs to save costs as Alzheimer’s drug launch gathers pace

  • Home
  • Healthcare
  • Biogen to cut 1,000 jobs to save costs as Alzheimer’s drug launch gathers pace
Investors have pinned their hopes on Leqembi as the U.S drugmaker’s money spinner multiple sclerosis and spinal muscular atrophy (SMA) treatments face fierce competition from cheaper versions and rival drugs.